Featured Research

from universities, journals, and other organizations

Research team designing new drug for common heart condition

Date:
October 7, 2013
Source:
University of Alberta Faculty of Medicine & Dentistry
Summary:
An international research team has shown that new medications based on resveratrol -- a compound found in red wine and nuts -- may be used to treat a common heart-rhythm problem known as atrial fibrillation.

An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol -- a compound found in red wine and nuts -- may be used to treat a common heart-rhythm problem known as atrial fibrillation.

Faculty of Medicine & Dentistry researcher Peter Light and his colleagues recently published their findings in the peer-reviewed journal, British Journal of Pharmacology. They discovered that new resveratrol-based drugs they created that were used in the lab, helped regulate electrical activity in the heart by inhibiting irregular electrical currents, and by reducing the length of abnormal heart-rhythm episodes. These new medications they created targeted multiple activities in the cell, whereas current medications for heart rhythm problems target just one or two specific areas.

The U of A team is now working on advancing their drug design with colleagues at the Centre for Drug Research and Development, and via TEC Edmonton. Light expects that clinical trials with the advanced drug design will start within the next three to five years.

"We are at the next stage of developing a new oral medication for atrial fibrillation that patients could take on a daily basis to prevent this condition from occurring," says Light. "We are improving the medication's solubility, absorption, how it is metabolized and how long it stays in the blood stream."

Few medications are currently on the market to help treat atrial fibrillation effectively and those medications may have many serious side effects. Because resveratrol is a natural product, Light and his colleagues hope the new drug would be better tolerated by the body.

It has long been known that resveratrol has cardio-protective effects and seems to prevent some rhythm disorders of the heart, lowers blood pressure and reduces enlargement of the heart.

"We have had a tremendous amount of success with resveratrol and have been at the leading edge of resveratrol research as it relates to cardiovascular disease so the transition to making new and improved medications based on resveratrol derivatives is a logical next step," says Jason Dyck, one of the researchers on the team.

Atrial fibrillation is the most common abnormal heart rhythm problem affecting 1 in 200 people. It carries a five-fold increased risk of stroke, as well as an increased risk of heart failure and death.


Story Source:

The above story is based on materials provided by University of Alberta Faculty of Medicine & Dentistry. Note: Materials may be edited for content and length.


Journal Reference:

  1. Istvan Baczko, David Liknes, Wei Yang, Kevin C Hamming, Gavin Searle, Kristian Jaeger, Zoltan Husti, Viktor Juhasz, Gergely Klausz, Robert Pap, Laszlo Saghy, Andras Varro, Vernon Dolinsky, Shaohua Wang, Vivek Rauniyar, Dennis Hall, Jason R. Dyck, Peter E. Light. Characterization of a novel multi-functional resveratrol derivative for the treatment of atrial fibrillation.. British Journal of Pharmacology, 2013; DOI: 10.1111/bph.12409

Cite This Page:

University of Alberta Faculty of Medicine & Dentistry. "Research team designing new drug for common heart condition." ScienceDaily. ScienceDaily, 7 October 2013. <www.sciencedaily.com/releases/2013/10/131007132248.htm>.
University of Alberta Faculty of Medicine & Dentistry. (2013, October 7). Research team designing new drug for common heart condition. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2013/10/131007132248.htm
University of Alberta Faculty of Medicine & Dentistry. "Research team designing new drug for common heart condition." ScienceDaily. www.sciencedaily.com/releases/2013/10/131007132248.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Newsy (July 30, 2014) The Peace Corps is one of several U.S.-based organizations to pull workers out of West Africa because of the Ebola outbreak. Video provided by Newsy
Powered by NewsLook.com
Weather Kills 2K A Year, But Storms Aren't The Main Offender

Weather Kills 2K A Year, But Storms Aren't The Main Offender

Newsy (July 30, 2014) Health officials say 2,000 deaths occur each year in the U.S. due to weather, but it's excessive heat and cold that claim the most lives. Video provided by Newsy
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins